期刊文献+

六君子汤对化疗荷瘤小鼠增效减毒作用的实验研究 被引量:3

Experimental study on synergy and attenuation of Liujunzi Decoction in tumor bearing mice treated with chemotherapy
原文传递
导出
摘要 目的探讨六君子汤对化疗药物环磷酰胺(CTX)抗S180小鼠的增效减毒作用。方法建立S180荷瘤小鼠模型,随机分为5组:荷瘤对照组、CTX组、六君子汤高、低剂量+CTX组及贞芪扶正胶囊+CTX组。观察瘤重、抑制率、脾脏及胸腺重量、肝肾功能、免疫球蛋白、脾脏一氧化氮(NO)的变化。结果六君子汤高、低剂量+CTX组肿瘤生长(瘤重)明显低于荷瘤对照组(P(0.01),且高剂量+CTX组肿瘤低于CTX组(P(0.05)。六君子汤高、低剂量+CTX组脾脏和胸腺指数、IgG水平升高,脾脏NO含量降低,与CTX组相比差异显著(P(0.05或P(0.01)。六君子汤高剂量+CTX组与CTX组相比,ALT降低(P(0.05)。结论六君子汤具有增强免疫功能,这可能是该药对化疗药物CTX抗S180小鼠增效减毒的作用机制。 Objective To investigate the synergy and beating mouse treated by eyclophosphamide (CTX). attenuation of Liujunzi Decoction to S180 tumor Methods S180 tumor beating mice were established and then divided randomly into five groups, including tumor-beating control group, CTX group, Liujunzi Decoction (high and low dose) plus CTX groups, and Zhenqifuzheng Capsules plus CTX group. We calculated the tumor-supression rate, measured the weights of spleen and thymus, observed the functions of liver and kidney and the change of immunoglobulin(Ig) ,detected the content of nitric oxide (NO) in spleen. Results ( 1 ) The tumor-weight-inhibiting rates were higher in each Liujunzi Decoction plus CTX group than in the tumor-beating control group(P 〈 0.01 ). The tumor-weight-inhibiting rates of Liujunzi Decoction high-dose plus CTX group were higher than that of CTX group ( P 〈 0.05 ). (2) Compared with the two Liujunzi Decoction plus CTX groups, the index of spleen and thymus, and the level of IgG in the CTX group were lower, and the content of NO in spleen were higher, which revealed significant differences( P 〈 0.05 or P 〈 0.01 ). (3) The level of serum ALT were higher in the CTX group than in the high dose Liujunzi Decoction plus CTX group (P 〈 0.05 ). Conclusion Liujunzi Decoction can enhance immunity and this could be the mechanism of the synergy and attenuation of Liujunzi Decoction on CTX activities in S180 tumor beating mouse.
出处 《北京中医药大学学报》 CAS CSCD 北大核心 2008年第11期767-769,774,共4页 Journal of Beijing University of Traditional Chinese Medicine
基金 河北大学自然科学基金资助项目(No.2006Q29)
关键词 六君子汤 S180小鼠 化疗 Liujunzi Decoction S180 mice chemotherapy
  • 相关文献

参考文献4

  • 1陈鹊汀,刘智勤,朱惠学,徐妍,王海波,胡庚坤,李勇,蒋玉凤,黄启福.当归补血汤联合环磷酰胺抗肿瘤实验研究[J].第三军医大学学报,2008,30(16):1568-1571. 被引量:20
  • 2张如刚,王兴旺.烷化剂-环磷酰胺.见:刘鲁明,杨宇飞.肿瘤科中西药物手册[M].北京:人民卫生出版社,2003:111-113.
  • 3KASTELAN Z, LUKAC E, DERZIC D, et al. Lymphocyte subsets lymphocyte reactivity to mitogens NK cell activity and neutrophil and monocyte phagocytic functions in patients with bladder carcinoma[J]. Anticancer Res, 2003, 23(6) : 5185 -5189.
  • 4HADDEN J W. Immunodeficiency and cancer prospects for correction [J]. Int Immunopharmacol, 2003, 3 (8) : 1061 - 1071.

二级参考文献8

  • 1冯雪梅,吕艳,祝彼得,刘啸.熟地和制首乌多糖对贫血小鼠骨髓有核细胞数和细胞周期的影响[J].四川中医,2006,24(6):17-19. 被引量:13
  • 2范颖,陈信义.当归补血汤的实验研究进展[J].中医药学刊,2006,24(9):1643-1646. 被引量:30
  • 3孙瑞元,马越鸣,洪宗元.药理实验设计及统计分析[M].徐淑云,如濂卞,陈修.药理实验方法学.第3版.北京:人民卫生出版社.2002:195-196.
  • 4丁岩,陈晓光.人参皂苷Rh2注射液对小鼠内瘤S180的抑瘤作用[M].陈奇.中药药理研究方法学.第2版.北京:人民卫生出版社.2006:1017-1018.
  • 5Kastelan Z, l,ukac E, Derezie D, et al. Lymphoeyte subsets, lymphocyte reaetivity to mitogens, NK cell aetivity and neutrophil and monocyte phagocytic functions in patients with bladder carcinoma[J]. Anticancer Res, 2003, 23(6D) : 5185 -5189.
  • 6Van-Sandick J W, Boermeester M A, Gisbertz S S, et al. Lymphocyte subsets and T(h) 1/T( h ) 2 immune responses in patients with adenocarcinoma of the nesophagus or oesnphagogastrie junction: relation to pTNM stage and clinical outcome[ J]. Cancer lmmunol lmmunother, 2003, 52(10) : 617 -624.
  • 7Hadden J W. Immunodeficiency and cancer: prospects for correction [J]. Int Immunopharmacol, 2003, 3(8): 1061 -1071.
  • 8张如刚,工兴旺.烷化剂-环磷酰胺[M]//刘鲁明,杨宇飞.肿瘤科中西药物手册.北京:人民卫生出版社,2003:111-113.

共引文献20

同被引文献16

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部